Ir para o conteúdo principal

United States Últimas notícias

Todas as matérias desta categoria, das mais recentes às mais antigas.

Grafa

Clearmind Medicine hits primary safety endpoint in Phase I/IIa alcohol use disorder trial

Clearmind Medicine (NASDAQ:CMND), a clinical-stage biopharmaceutical company focused on neuro-therapeutics, announced on Tuesday, April 14, 2026, that its lead oral candidate, CMND-100, successfully met the primary safety and tolerability endpoints in an FDA-approved Phase I/IIa dose-escalation trial.

Leia mais: Clearmind Medicine hits primary safety endpoint in Phase I/IIa alcohol use disorder trial
Grafa

Hoth Therapeutics preclinical data shows GDNF reprograms liver fat metabolism

Hoth Therapeutics (NASDAQ:HOTH) announced on Tuesday, April 14, 2026, positive preclinical results for its HT-VA program, showing that parenteral administration of Glial Cell-Derived Neurotrophic Factor (GDNF) can fundamentally alter liver fat metabolism.

Leia mais: Hoth Therapeutics preclinical data shows GDNF reprograms liver fat metabolism
Grafa
Technology

Horizon Aircraft advances Cavorite X7 development with new strategic partnerships

Horizon Aircraft (NASDAQ:HOVR) reported its third-quarter fiscal 2026 financial results on Tuesday, April 14, 2026, detailing a strengthened balance sheet and a series of manufacturing milestones intended to bring its flagship hybrid-electric aircraft to market by 2027.

Leia mais: Horizon Aircraft advances Cavorite X7 development with new strategic partnerships